Elon Musk, CEO of Tesla has grabbed the news headlines yet again. In the latest updates, he has reportedly joined the researchers to track the Covid 19 infection with the 4000 SpaceX workers who volunteered.
Elon Musk To Facilitate Covid 19 Studies
Reports suggest that the study in which Elon Musk is working as the co-author will study the threshold of antibodies of the coronavirus. The study will include how long the antibodies in the human body are able to provide protection against the coronavirus.
The study began last year when SpaceX was preparing to send a “manned mission” to the sky. As per the reports, the study is being done by Elon Musk along with the Top Medical Executives at SpaceX. It includes doctors and academic researchers. They will work towards building an antibody testing programme which will be tested on 4000 SpaceX employees via monthly blood tests.
ALSO READ: Elon Musk reclaims position as world’s richest man
Heavy Challenges Force Heavier Immunity Response
So far the studies suggest that the people who experienced mild fever or milder symptoms for the Coronavirus infection were able to generate fewer antibodies within their system. Hence, they were less likely to be able to sustain long-term immunity.
The immunity in the body works to generate a fast and strong or a weak response towards a virus. It could be dependent on the host-pathogen interaction or inflammatory cues or be dependent on the level of viral challenge.
The study has been published in the journal Nature Communication. It says that the low-level challenge may last only for a week and work with the poorly functioning antibodies. However, if the immunity is higher and the burden of the challenge is higher, it is possible to create a heavy functioning immune response and be able to respond aggressively.
ALSO READ: Jeff Bezos Topples Elon Musk To Become The World’s Richest Person After 3 Years
The study further notes that unlike the mild infections and natural asymptomatic symptoms can be easily ruled out by the SARS-CoV-2 vaccines as they intend to quicken the immunity system’s responses towards the virus.
Meanwhile, people who had already encountered the infection before and were reinfected with the same viral had low number of antibodies.
“People can have antibodies, but it doesn’t mean they are going to be immune,” Galit Alter, one of the doctors who co-authored and a professor of medicine at Harvard Medical School.
ALSO READ: Elon Musk owned Tesla finally enters India
Alter further said that the good news is in the fact that some of the vaccines induce antibodies within the immunity system which in result gives it the boost and ability to respond quickly in case they encounter the infection again. However, this would require multiple rounds of immunizations to further boost the immune system.
